Korpela R, Silvola J, Laakso E, Meretoja O A
Department of Anaesthesia and Intensive Care, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
Acta Anaesthesiol Scand. 2007 Jul;51(6):726-30. doi: 10.1111/j.1399-6576.2007.01319.x. Epub 2007 Apr 26.
Our aim was to show the efficacy of naproxen and paracetamol with and without pethidine on pain and nausea and vomiting after adenoidectomy. The primary outcome was the requirement of rescue analgesic for post-operative pain and the secondary outcome was post-operative nausea and vomiting (PONV).
A randomized, double-blind, placebo-controlled study design was used. Thirty minutes before anaesthesia induction, patients (n= 180) received either a single oral dose analgesic (naproxen 10 mg/kg or paracetamol 20 mg/kg) or a placebo. Half of the children received pethidine 1 mg/kg intravenously (i.v.) at the induction of anaesthesia. Post-operative pain was evaluated using an objective behavioural pain scale (OPS 0-9) and rescue medication, i.v. fentanyl 1 mug/kg, was administered if the child suffered from moderate or severe pain (OPS > or = 4).
When pethidine was not used, 83% of the children in the naproxen group vs. 97% in the other two groups required rescue fentanyl (P < 0.05). The use of pethidine reduced the incidence of fentanyl requirement by 30% and the number of fentanyl doses by 50% (P < 0.001). It also equalized the effects of naproxen, paracetamol and the placebo making the pain model invalid for this kind of study. The drawback associated with better analgesia was a doubling of the incidence of PONV (P < 0.001).
Oral naproxen (10 mg/kg), but not oral paracetamol (20 mg/kg), reduces the need for rescue analgesic after adenoidectomy in children. The sensitivity of the pain model is crucial for these types of studies.
我们的目的是展示萘普生和对乙酰氨基酚在使用或不使用哌替啶的情况下,对腺样体切除术后疼痛、恶心和呕吐的疗效。主要结局是术后疼痛所需的解救镇痛药,次要结局是术后恶心和呕吐(PONV)。
采用随机、双盲、安慰剂对照研究设计。在麻醉诱导前30分钟,患者(n = 180)接受单次口服剂量镇痛药(萘普生10 mg/kg或对乙酰氨基酚20 mg/kg)或安慰剂。一半儿童在麻醉诱导时静脉注射(i.v.)哌替啶1 mg/kg。使用客观行为疼痛量表(OPS 0 - 9)评估术后疼痛,如果儿童出现中度或重度疼痛(OPS≥4),则静脉注射芬太尼1 μg/kg作为解救药物。
未使用哌替啶时,萘普生组83%的儿童需要解救芬太尼,而其他两组为97%(P < 0.05)。使用哌替啶使芬太尼需求发生率降低了30%,芬太尼剂量数量减少了50%(P < 0.001)。它还使萘普生、对乙酰氨基酚和安慰剂的效果均等,使这种疼痛模型不适用于此类研究。与更好的镇痛效果相关的缺点是PONV发生率翻倍(P < 0.001)。
口服萘普生(10 mg/kg),而非口服对乙酰氨基酚(20 mg/kg),可减少儿童腺样体切除术后对解救镇痛药的需求。疼痛模型的敏感性对这类研究至关重要。